PAHC Phibro Animal Health Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PAHC

Price (delayed)

$30.53

Market cap

$1.24B

P/E Ratio

13.05

Dividend/share

$0.48

EPS

$2.34

Enterprise value

$1.92B

?
Relative Growth: Rel. Growth: 93
Relative Strength: Rel. Strength: 18
Relative Valuation: Rel. Valuation: 95
Relative Profitability: Rel. Profitability: 80

Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce ...

Highlights
PAHC's net income has surged by 200% year-on-year and by 3.4% since the previous quarter
PAHC's EPS has surged by 196% year-on-year and by 3.1% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.pahc.com
Peers: ICCC MRK ZTS LLY

Key stats

What are the main financial stats of PAHC

PAHC stock price

How has the Phibro Animal Health stock price performed over time
Intraday
-1.74%
1 week
-4.2%
1 month
-8.21%
1 year
24.82%
YTD
-18.28%
QTD
-44.8%

Financial performance

How have Phibro Animal Health's revenue and profit performed over time
Revenue
$1.5B
Gross profit
$488.12M
Operating income
$179.96M
Net income
$95.23M
Gross margin
32.5%
Net margin
6.3%
PAHC's net income has surged by 200% year-on-year and by 3.4% since the previous quarter
PAHC's net margin has soared by 133% YoY
PAHC's operating income has surged by 89% year-on-year and by 7% since the previous quarter
The operating margin has surged by 50% year-on-year and by 4.3% since the previous quarter

Price vs fundamentals

How does PAHC's price correlate with its fundamentals

Growth

What is Phibro Animal Health's growth rate over time

Valuation

What is Phibro Animal Health stock price valuation
PAHC P/E details
P/E
13.05
P/B
3.42
P/S
0.83
EV/EBIT
11.18
EV/EBITDA
8.63
EV/Sales
1.28
PAHC's EPS has surged by 196% year-on-year and by 3.1% since the previous quarter
PAHC's P/E is 64% below its 5-year quarterly average of 36.7 and 39% below its last 4 quarters average of 21.4
The equity is up by 36% year-on-year and by 9% since the previous quarter
PAHC's P/B is 30% below its last 4 quarters average of 4.9 but 7% above its 5-year quarterly average of 3.2
The revenue has increased by 26% year-on-year and by 2.4% since the previous quarter
The stock's price to sales (P/S) is 25% less than its last 4 quarters average of 1.1 but 3.8% more than its 5-year quarterly average of 0.8

Efficiency

How efficient is Phibro Animal Health business performance
Phibro Animal Health's ROA has soared by 143% YoY
The return on equity has surged by 138% year-on-year but it has declined by 4.2% since the previous quarter
The ROIC has soared by 71% YoY
PAHC's return on sales has surged by 68% year-on-year

Dividends

What is PAHC's dividend history
Dividend details
DPS
$0.48
Dividend yield
1.57%
Payout ratio
20.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Phibro Animal Health financials performed over time
Phibro Animal Health's total assets is 33% higher than its total liabilities
Phibro Animal Health's total assets has increased by 10% YoY and by 2.8% QoQ
Phibro Animal Health's current ratio has increased by 9% YoY and by 3.9% QoQ
PAHC's debt is 103% higher than its equity
The equity is up by 36% year-on-year and by 9% since the previous quarter
PAHC's debt to equity is down by 26% YoY and by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.